The implementation of FDAAA has put the spotlight on drug safety in a way previously unknown. Pharmaceutical companies are devoting more attention and ultimately more money towards carefully understanding, communicating and monitoring the risks and benefits of their products. Along with the more stringent requirements by the FDA, there is greater media attention and consumer awareness that further drives pharmaceutical companies to take precautions and greater responsibility.

The initial confusion around understanding the newly implemented safety regulations has lifted significantly. Essentially, the FDA wants increased patient safety as well as more accountability on the part of the drug company. The question that now remains is how best to achieve this.
Meeting drug safety measures reaches beyond simply implementing a strategy, as there are various degrees to which drug safety needs to be monitored, from simple patient guidelines that explain drug risk/benefit to tightly monitored environments for drug distribution.

After a highly successful event last year, ExL Pharma is proud to bring you our 2nd annual conference on Developments in Drug Safety.

Gain the most practical information on meeting drug safety standards

Hear from industry experts on best practices for completing REMS Learn about new developments and how to prepare for them now, learn how to incorporate safety measures at every step of the development process, prepare yourself by learning from tried and tested methods of drug safety.